CIK: 0001232621 · Show all filings
Period: Q4 2020 (← Previous) (Next →)
Filing Date: Feb 16, 2021
Total Value ($000): $655,025 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ODONATE THERAPEUTICS INC | 15,514,566 | $297,880 | 45.5% | $24.10 | — | COM | 676079106 |
| RCKT | ROCKET PHARMACEUTICALS INC | 2,965,485 | $162,627 | 24.8% | $16.31 | +123.5% | COM | 77313F106 |
| — | APTEVO THERAPEUTICS INC | 1,760,000 | $64,504 | 9.8% | $36.65 | — | COM NEW | 03835L207 |
| ANAB | ANAPTYSBIO INC | 2,628,678 | $56,517 | 8.6% | $21.51 | +12.9% | COM | 032724106 |
| — | LA JOLLA PHARMACEUTICAL CO | 9,405,490 | $36,493 | 5.6% | $10.35 | — | COM | 503459604 |
| CHRS | COHERUS BIOSCIENCES INC | 650,000 | $11,297 | 1.7% | $17.90 | -0.5% | COM | 19249H103 |
| — | VINCERA PHARMA INC | 500,000 | $9,630 | 1.5% | $19.26 | — | UNIT 12/24/2025 | 92731L205 |
| RLMD | RELMADA THERAPEUTICS INC | 200,000 | $6,414 | 1.0% | $28.22 | +21.8% | COM | 75955J402 |
| — | BCTG ACQUISITION CORP | 468,750 | $5,363 | 0.8% | $10.36 | — | COM | 05492W103 |
| EQ | EQUILLIUM INC | 600,000 | $3,210 | 0.5% | $5.23 | 0.0% | COM | 29446K106 |
| — | VINCERA PHARMA INC | 330,205 | $1,090 | 0.2% | $3.30 | — | *W EXP 12/24/202 | 92731L114 |